When was TriNetX founded?

TriNetX was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is TriNetX located?

TriNetX is headquartered in Cambridge, United States. It is registered at Cambridge,Massachusetts.

Who is the current CEO of TriNetX?

Gadi Lachman of TriNetX. They have also founded 1 company.

How many employees does TriNetX have?

As of Aug 31, 2026, the latest employee count at TriNetX is 271.

Is TriNetX a funded company?

TriNetX is a funded company, having raised a total of $102M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 2014.

How much is TriNetX worth?

The last known valuation of TriNetX was $***** as of Apr 09, 2019.

When was the latest funding round of TriNetX?

TriNetX's latest funding was a $***** Series D round on Mar 13, 2019, with participation from 6 investors.

Where does TriNetX rank among its competitors?

TriNetX ranks 7th amongst 320 active competitors, of which 54 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Tempus, which secured $460M in Jul, 2026.

Who are the top competitors of TriNetX?

TriNetX's top competitors include Medidata, Verily and IQVIA. Among them, Tempus secured the most recent funding round in July, 2026.

TriNetX - 2026 Company Profile, Team, Funding & Competitors

Company Details

TriNetX offers clinical trial management software for researchers and professionals. The company has developed tools like TriNetX Analyze that assist in analyzing clinical trial data, TriNetX Research that gives a comparative analysis of treatment and outcomes, TriNetX Analyze assist in analyzing medical reports for medication conflicts, and more. The TriNetX Network, allows researchers/sponsors to analyze patient populations, refine clinical study assumptions, and ultimately locate the best clinical sites and successfully recruit patients to their study. It enables pharmaceutical companies, healthcare providers, and CROs to truly leverage patient data in a way that fosters collaboration and efficiency in clinical research to make a lasting impact on drug development and bring new therapies to market faster.

Website: trinetx.com/
Social
Email ID: *****@trinetx.com
Phone Number: +1 **********
Registered Address: Cambridge,Massachusetts

Key Metrics

Founded Year

2013

Location

Cambridge, United States

Stage

Acquired

Total Funding

$102M in 2 rounds

Latest Funding Round

Series D, Mar 13, 2019, $*****

Last Known Valuation

$***** as on Apr 09, 2019

Investors

Merck Global Health Innovation Fund & 7 more

Ranked

7^th among 320 active competitors

Employee Count

271 as on Aug 31, 2026

Investment & Acquisitions

Advera Health & 2 more

Similar Companies

Medidata & 363 more

Exit Details

Acquired by The Carlyle Group (Sep 21, 2020)

View TriNetX's full profile

TriNetX is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TRINETX, LLC CIN: 32081492756 , United States, Deadpooled	Oct 13, 2021	-	-	-
TRINETX, LLC CIN: 853257141 , United States, Active	Dec 31, 1999	-	192 (As on Dec 31, 2024)	-
TRINETX, INC CIN: 463329632 , United States, Active	Dec 31, 1999	-	162 (As on Dec 31, 2021)	-

TriNetX got acquired by The Carlyle Group on Sep 21, 2020.

Click here to take a look at TriNetX's acquisition in detail

TriNetX has raised a total funding of $102M over 2 rounds. Its first funding round was on Jun 2014. Its latest funding round was a Series D round on Mar 13, 2019 for $*****. 6 investors participated in its latest round. TriNetX has 8 institutional investors.

Here is the list of recent funding rounds of TriNetX:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 13, 2019	6047488	Series D	9507164	7279561	1230689	1945728
Jun 2014	1472583	Series A	4514054	5347195	2237216	1028446

Access funding benchmarks and valuations. Sign up today!

View details of TriNetX's funding rounds and investors

The founders of TriNetX is Gadi Lachman. Gadi Lachman is the CEO of TriNetX.

Here are the details of TriNetX's key team members:

Gadi Lachman: Founder & CEO of TriNetX.

View details of TriNetX's Founder profiles and Board Members

TriNetX's employee count trend

TriNetX has 271 employees as of Aug 26. Here is TriNetX's employee count trend over the years:

Uncover TriNetX's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TriNetX include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of TriNetX, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Aisling Capital ... & 12 others	80/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	T. Rowe Price, New Enterprise Associates ... & 11 others	77/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	70/100
7th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	F2 Ventures, Deerfield & 6 others	66/100
8th	Wcg Clinical 2012, Princeton (United States), Acquired	CRO offering regulatory and ethical review services for clinical research	-	Ares Capital Corporation, Prospect Capital ... & 6 others	64/100
9th	Obvio Health 2015, Orlando (United States), Series B	Provider of clinical trials design and recruitment platform	$66M	Dedalus Group, Guardant Health & 13 others	62/100
10th	Autonomize 2021, Austin (United States), Series A	AI-based drug discovery tool for researchers	$32M	Cigna Ventures, Tau Ventures & 8 others	61/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on TriNetX's competitors? Click here to see the top ones

TriNetX has acquired 3 companies including Advera Health, InSite and Custodix. TriNetX has not made any investments as of now.

Here is the list of its acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 21, 2022	Acquisition	Advera Health	2010	Santa Rosa (United States)
Apr 02, 2019	Acquisition	InSite	2015	Sint Martens Latem (Belgium)
Apr 02, 2019	Acquisition	Custodix	2000	Sint-Martens-Latem (Belgium)